KKR: €1.2 Billion Acquisition of Medicover India Stake

• KKR has agreed to acquire Medicover's entire stake in Sahrudaya Health Care Private Limited for €1.2 billion.
• The transaction was led by Reeba Chacko and Kota Chandan from Cyril Amarchand Mangaldas.
• Trilegal advised minority shareholders on the sale of their stake to KKR.
• McDermott Will & Schulte also advised Medicover and some minority shareholders on the deal.

Private equity giant KKR has made a significant move in the Indian healthcare market, agreeing to acquire the entire stake held by Medicover in Sahrudaya Health Care Private Limited for approximately €1.2 billion.

Private equity giant KKR has made a significant move in the Indian healthcare market, agreeing to acquire the entire stake held by Medicover in Sahrudaya Health Care Private Limited for approximately €1.2 billion. This acquisition marks a major milestone in the country's growing healthcare sector and is likely to set a precedent for future deals. The transaction was led by Reeba Chacko (Senior Partner) and Kota Chandan (Partner) from Cyril Amarchand Mangaldas, who represented Medicover on this deal.

The acquisition is significant not only for its value but also for the implications it may have on future private equity transactions in India. Lawyers advising clients on such deals should be aware of the potential impact on compliance with Indian regulations. The transaction involved complex structuring, including third-party financing repayment and ECB assignment, which required expertise from multiple firms, including Trilegal and McDermott Will & Schulte. These firms advised on various aspects of the deal, including transaction structuring, definitive documents, ESOP settlement mechanisms, and transitional license agreements.

This acquisition is a testament to India's growing appeal as a destination for private equity investments. The deal's value and complexity are likely to set a new benchmark for future transactions in the country. Moreover, it highlights the importance of regulatory compliance in such deals, which may have far-reaching implications for lawyers advising clients on similar transactions. As the Indian healthcare sector continues to grow, this acquisition is expected to pave the way for further investments in the sector.

Lawyers advising clients on private equity transactions should be aware of the implications of KKR's €1.2 billion acquisition of Medicover India, which may set a precedent for future deals and impact compliance with Indian regulations.

Source: Original reporting via Cyril Amarchand Mangaldas, Trilegal, AZB